摘要
我国的随机对照临床试验中越来越多设立数据和安全监察委员会(DSMB),但在组织和操作过程中缺少具体的法规指导和支持。本文结合国际指南、文献、实践经验,设计数据和安全监察委员会章程,内容包括:简介、专家组成、责职、会议纪要、递交给DSMB的报告、DSMB建议及文件存档等,并提供模板文件供业界参考。
The data and safety monitoring board (DSMB) from randomized controlled trials (RCTs) is becoming more common in our country, but with little guidance on how they should operate. We develop a charter template for DSMB in clinical trial on the basis of international guidelines, literature and our experience for reference. The content includes introduction, composition, responsibility, minutes of meeting, communication reports to DSMB, recommendations of DSMB, document retention and so on.
作者
何迎春
吕映华
杨娟
HE Ying-chun LU Ying-hua YANG Juan(Center for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, SHANGHAI 201203, China)
出处
《中国新药与临床杂志》
CAS
CSCD
北大核心
2016年第9期643-648,共6页
Chinese Journal of New Drugs and Clinical Remedies
基金
上海市中医药事业发展计划(ZY3-CCCX-3-1001)
上海市教委预算内项目(2013JW19
2014YSN17)
中药学创新研究基金项目(ZYX-CXYJ-003)
关键词
临床试验
管理委员会
章程和细则
clinical trial
governing board
constitution and bylaws